English  |  正體中文  |  简体中文  |  总笔数 :2856565  
造访人次 :  53389799    在线人数 :  1011
教育部委托研究计画      计画执行:国立台湾大学图书馆
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
关于TAIR

浏览

消息

著作权

相关连结

"hung c c"的相关文件

Return to Browse by Author
Sorting by Title Sort by Date

Showing items 21-45 of 1701  (69 Page(s) Totally)
1 2 3 4 5 6 7 8 9 10 > >>
View [10|25|50] records per page

Institution Date Title Author
臺大學術典藏 2022-09-19T03:16:30Z Increased fracture risk after discontinuation of anti-osteoporosis medications among hip fracture patients: A population-based cohort study Fu S.-H.; Wang C.-Y.; Hung C.-C.; Lee C.-C.; Yang R.-S.; Huang C.-C.; Farn C.-J.; Lin W.-H.; Chen H.-M.; FEI-YUAN HSIAO; Lin J.-W.; Li C.-Y.
臺大學術典藏 2022-09-19T03:16:26Z Impact of the Requirement of Bone Mineral Density Evidence on Utilization of Anti-osteoporosis Medications, Clinical Outcome and Medical Expenditures of Patient With Hip Fracture in Taiwan Wang C.-Y.; Fu S.-H.; Hung C.-C.; Yang R.-S.; Lin J.-W.; Chen H.-M.; FEI-YUAN HSIAO; Shen L.-J.
臺大學術典藏 2022-09-16T08:49:06Z Acute HIV infection with presentations mimicking acalculous cholecystitis: A case report Liu W.-D.; Cheng C.-N.; Lin Y.-T.; CHING-HUA KUO; Ho S.-Y.; Hung C.-C.
臺大學術典藏 2022-09-16T08:49:04Z Short-course daily isoniazid and rifapentine for latent tuberculosis infection in people living with HIV who received coformulated bictegravir/emtricitabine/tenofovir alafenamide Liou B.-H.; Cheng C.-N.; Lin Y.-T.; Lin Y.-J.; Chuang Y.-C.; Lin K.-Y.; Liu W.-C.; Lin S.-W.; CHING-HUA KUO; Sun H.-Y.; Hung C.-C.
臺大學術典藏 2022-09-15T05:50:20Z Impact of the initial wave of COVID-19 pandemic in Taiwan on local HIV services: Results from a cross-sectional online survey WANG-DA LIU; Wang H.-Y.; Du S.-C.; Hung C.-C.
臺大學術典藏 2022-09-15T05:50:19Z Primary hypogammaglobulinemia presenting with prostate abscess and Fusobacterium mortiferum bacteremia in a 28-year-old man Lu C.-H.; WANG-DA LIU; Huang C.-F.; Liao C.-H.; Lan T.-Y.; Kang C.-M.; Lin C.-C.; Yang Y.-H.; Hung C.-C.
臺大學術典藏 2022-09-15T05:50:19Z Hepatitis C microelimination among people living with HIV in Taiwan Chen G.-J.; Ho S.-Y.; Su L.-H.; Chang S.-Y.; Hsieh S.-M.; Sheng W.-H.; WANG-DA LIU; Huang Y.-S.; Lin K.-Y.; Chen Y.-T.; Su Y.-C.; Liu W.-C.; Sun H.-Y.; Hung C.-C.
臺大學術典藏 2022-09-15T05:50:18Z Accelerated progression of pulmonary tuberculosis in a COVID-19 patient after corticosteroid treatment WANG-DA LIU; Wang J.-T.; Hung C.-C.; Chang S.-C.
臺大學術典藏 2022-09-15T05:50:18Z Effectiveness of COVID-19 vaccination among people living with HIV during a COVID-19 outbreak Lin K.-Y.; Wu P.-Y.; WANG-DA LIU; Sun H.-Y.; Hsieh S.-M.; Sheng W.-H.; Huang Y.-S.; Hung C.-C.; Chang S.-C.
臺大學術典藏 2022-09-15T05:50:17Z Low-level viraemia and virologic failure among people living with HIV who received maintenance therapy with co-formulated bictegravir, emtricitabine and tenofovir alafenamide versus dolutegravir-based regimens Chen G.-J.; Sun H.-Y.; Chen L.-Y.; Hsieh S.-M.; Sheng W.-H.; WANG-DA LIU; Chuang Y.-C.; Huang Y.-S.; Lin K.-Y.; Wu P.-Y.; Chang H.-Y.; Luo Y.-Z.; Su Y.-C.; Liu W.-C.; Chang S.-F.; Chang S.-Y.; Hung C.-C.
臺大學術典藏 2022-09-15T05:50:17Z Performance of Hepatitis C Virus (HCV) Core Antigen Assay in the Diagnosis of Recently Acquired HCV Infection among High-Risk Populations Sun H.-Y.; WANG-DA LIU; Wang C.-W.; Wei Y.-J.; Lin K.-Y.; Huang Y.-S.; Su L.-H.; Chen Y.-T.; Liu W.-C.; Su Y.-C.; Chen Y.-W.; Chuang Y.-C.; Lu P.-L.; Hung C.-C.; Yu M.-L.
臺大學術典藏 2022-09-09T04:21:39Z Evolution of estimated glomerular filtration rate in human immunodeficiency virus and hepatitis C virus-coinfected patients receiving sofosbuvir-based direct-acting antivirals and antiretroviral therapy Liu C.-H.; Sun H.-Y.; Hsieh S.-M.; Liu W.-C.; Sheng W.-H.; Liu C.-J.; Su T.-H.; Tseng T.-C.; Chen P.-J.; Hung C.-C.; JIA-HORNG KAO
臺大學術典藏 2022-09-09T04:21:16Z Hepatitis C Virus Reinfection in People With HIV in Taiwan After Achieving Sustained Virologic Response With Antiviral Treatment: The RECUR Study Liu C.-H.; Sun H.-Y.; Peng C.-Y.; Hsieh S.-M.; Yang S.-S.; Kao W.-Y.; Shih Y.-L.; Lin C.-L.; Liu C.-J.; Sheng W.-H.; Lo Y.-C.; Liu W.-C.; Wu J.-H.; Su T.-H.; Tseng T.-C.; Chen P.-J.; Hung C.-C.; JIA-HORNG KAO
臺大學術典藏 2022-09-07T07:42:15Z Low prevalence of Helicobacter pylori but high prevalence of cytomegalovirus-associated peptic ulcer disease in AIDS patients: Comparative study of symptomatic subjects evaluated by endoscopy and CD4 counts HAN-MO CHIU; Wu M.-S.; Hung C.-C.; Shun C.-T.; Lin J.-T.
臺大學術典藏 2022-09-07T06:39:31Z Do we still need lead-in dosing of Nevirapine in HIV-infected patients who are receiving rifampicin-containing antituberculous therapy? Chang S.-Y.; SHU-WEN LIN; Hung C.-C.
臺大學術典藏 2022-09-07T06:39:27Z Nemonoxacin (TG-873870) for treatment of community-acquired pneumonia Lai C.-C.; Lee K.-Y.; SHU-WEN LIN; Chen Y.-H.; Kuo H.-Y.; Hung C.-C.; Hsueh P.-R.
臺大學術典藏 2022-09-07T06:39:26Z Therapeutic drug monitoring and pharmacogenetic, study of HIV-infected ethnic chinese receiving efavirenz-containing antiretroviral therapy with or without rifampicin-based anti-tuberculous therapy Lee K.-Y.; SHU-WEN LIN; Sun H.-Y.; Kuo C.-H.; Tsai M.-S.; Wu B.-R.; Tang S.-Y.; Liu W.-C.; Chang S.-Y.; Hung C.-C.
臺大學術典藏 2022-09-07T06:39:25Z Multicenter study of trimethoprim/sulfamethoxazole-related hepatotoxicity: Incidence and associated factors among HIV-infected patients treated for Pneumocystis jirovecii pneumonia Yang J.-J.; Huang C.-H.; Liu C.-E.; Tang H.-J.; Yang C.-J.; Lee Y.-C.; Lee K.-Y.; Tsai M.-S.; SHU-WEN LIN; Chen Y.-H.; Lu P.-L.; Hung C.-C.
臺大學術典藏 2022-09-07T06:39:24Z Incidence and risk factors of skin rashes and hepatotoxicity in HIV-infected patients receiving nevirapine-containing combination antiretroviral therapy in Taiwan Tseng Y.-T.; Yang C.-J.; Chang S.-Y.; SHU-WEN LIN; Tsai M.-S.; Liu W.-C.; Wu P.-Y.; Su Y.-C.; Luo Y.-Z.; Yang S.-P.; Hung C.-C.; Chang S.-C.
臺大學術典藏 2022-09-07T06:39:23Z Cholelithiasis and nephrolithiasis in HIV-positive patients in the era of combination antiretroviral therapy Lin K.-Y.; Liao S.-H.; Liu W.-C.; Cheng A.; SHU-WEN LIN; Chang S.-Y.; Tsai M.-S.; Kuo C.-H.; Wu M.-R.; Wang H.-P.; Hung C.-C.; Chang S.-C.
臺大學術典藏 2022-09-07T06:39:22Z Presence of tablet remnants of nevirapine extended-release in stools and its impact on virological outcome in HIV-1-infected patients: A prospective cohort study Lee Y.-C.; SHU-WEN LIN; Chen M.-Y.; Chang S.-Y.; Kuo C.-H.; Sheng W.-H.; Hsieh S.-M.; Sun H.-Y.; Chang H.-Y.; Wu M.-R.; Liu W.-C.; Wu P.-Y.; Yang S.-P.; Zhang J.-Y.; Su Y.-C.; Luo Y.-Z.; Hung C.-C.; Chang S.-C.
臺大學術典藏 2022-09-07T06:39:18Z Treatment response to unboosted atazanavir in combination with tenofovir disoproxil fumarate and lamivudine in human immunodeficiency virus-1-infected patients who have achieved virological suppression: A therapeutic drug monitoring and pharmacogenetic study Tsai M.-S.; Chang S.-Y.; SHU-WEN LIN; Kuo C.-H.; Sun H.-Y.; Wu B.-R.; Tang S.-Y.; Liu W.-C.; Su Y.-C.; Hung C.-C.; Chang S.-C.
臺大學術典藏 2022-09-07T06:39:12Z Implementation and outcomes of a therapeutic drug monitoring program for antifungal and antiretroviral agents in a tertiary medical center in Taiwan SHU-WEN LIN; Kuo C.-H.; Shen L.-J.; Chen Y.-C.; Hung C.-C.; Wu F.-L.L.
臺大學術典藏 2022-09-07T06:39:12Z Effectiveness of half-a-tablet efavirenz plus 2 nucleos(t)ide reverse-transcriptase inhibitors as maintenance therapy with the guidance of therapeutic drug monitoring among virologically suppressed HIV-positive patients: A prospective study Huang S.-H.; SHU-WEN LIN; Chang S.-Y.; Lin Y.-T.; Sun H.-Y.; Liu W.-C.; Su Y.-C.; Hung C.-C.; Chang S.-C.
臺大學術典藏 2022-09-07T06:39:07Z Impact of Efavirenz Mid-dose Plasma Concentration on Long-Term Weight Change Among Virologically Suppressed People Living With HIV Huang S.-H.; Huang W.-C.; SHU-WEN LIN; Chuang Y.-C.; Sun H.-Y.; Chang S.-Y.; Kuo P.-H.; Wu P.-Y.; Liu W.-C.; Chiang C.; Hung C.-C.; Chang S.-C.

Showing items 21-45 of 1701  (69 Page(s) Totally)
1 2 3 4 5 6 7 8 9 10 > >>
View [10|25|50] records per page